Vital Therapies (VTL) Reports In-Line Q3 EPS

Vital Therapies (NASDAQ: VTL) reported Q3 EPS of ($0.32), in-line with the analyst estimate of ($0.32).

For earnings history and earnings-related data on Vital Therapies (VTL) click here.

You May Also Be Interested In

• BofA sees Micron EPS topping $230 by FY30, calls peak fears overblown
• Is Treasury selloff a major issue for stock market bulls?
• Vislink Technologies Inc. (VISL) Misses Q2 EPS by 7c